Amgen Inc (AMGN)

AMGN (NASDAQ:Drugs) EQUITY
$159.44
neg -2.67
-1.65%
Today's Range: 159.24 - 162.19 | AMGN Avg Daily Volume: 3,455,600
Last Update: 05/05/15 - 4:14 PM EDT
Volume: 3,073,323
YTD Performance: 0.67%
Open: $161.31
Previous Close: $162.11
52 Week Range: $109.41 - $173.60
Oustanding Shares: 760,323,664
Market Cap: 121,925,502,759
6-Month Chart
TheStreet Ratings Grade for AMGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 5
Moderate Buy 1 2 2 2
Hold 8 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.13 2.09 2.09 2.17
Latest Dividend: 0.79
Latest Dividend Yield: 1.97%
Dividend Ex-Date: 05/12/15
Price Earnings Ratio: 21.64
Price Earnings Comparisons:
AMGN Sector Avg. S&P 500
21.64 21.60 28.59
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
5.32% 43.77% 126.85%
GROWTH 12 Mo 3 Yr CAGR
Revenue 7.40 0.29 0.09
Net Income 1.50 0.40 0.12
EPS 0.90 0.67 0.18
Earnings for AMGN:
EBITDA 8.74B
Revenue 20.06B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $2.42 $2.38 $9.56 $10.61
Number of Analysts 11 10 12 13
High Estimate $2.62 $2.52 $9.86 $11.16
Low Estimate $2.32 $2.24 $9.24 $10.24
Prior Year $2.37 $2.30 $8.68 $9.56
Growth Rate (Year over Year) 2.30% 3.48% 10.18% 10.92%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

Cisco Is Connecting the Dots Real Money Pro($)

CSCO has corrected to a stronger support level and may be on the verge of moving higher.
March quarter earnings take a front seat.
There's plenty of green on the screen.
Gilead's Relative Strength Index slope is very strong.
Gilead's Relative Strength Index slope is very strong.
Bullish
Apr 22, 2015 | 7:16 AM EDT
Shares of AMGN now seen reaching $195, according to Jefferies. Company is seeing higher sales and keeping a tight lid on costs. Buy rat...
It's totally unremarkable, but there's no major weakness.
Also, GE in talks with Well Fargo over commercial portfolio.

An Earnings Overview Real Money Pro($)

Investors should learn whether results can support stock prices.

It's Time to Play Defense Real Money Pro($)

I am growing pessimistic about the market's upside potential.

Columnist Conversations

Not only a mega acquisition of Salesforce (CRM) by Microsoft (MSFT) can save the market from declines across t...
I have added across the board and aggressively to my long exposure in this sector.
The powerful surge that followed UPS's April 28th earnings report has hit a wall. Shares jumped over 3.4%...
GDP
After the wider than expected Trade Deficit Goldman Sachs has reduced their 1Q2015 Real GDP tracking estimate ...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.